DekaBank Deutsche Girozentrale - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 207 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$71,000
-91.8%
4,000
-87.7%
0.00%
-100.0%
Q3 2019$871,000
-51.3%
32,500
-51.5%
0.01%
-44.4%
Q2 2019$1,788,000
+47.8%
67,000
+56.7%
0.01%
+28.6%
Q1 2019$1,210,000
+108.3%
42,754
+19.4%
0.01%
+75.0%
Q4 2018$581,000
-52.0%
35,804
-16.3%
0.00%
-42.9%
Q3 2018$1,210,000
-43.0%
42,754
-23.5%
0.01%
-50.0%
Q2 2018$2,123,000
+155.8%
55,870
+115.7%
0.01%
+133.3%
Q1 2018$830,000
-46.6%
25,900
-8.8%
0.01%
-50.0%
Q4 2017$1,553,0000.0%28,4000.0%0.01%0.0%
Q3 2017$1,553,000
-3.1%
28,4000.0%0.01%
-7.7%
Q2 2017$1,602,000
+45.0%
28,4000.0%0.01%
+30.0%
Q1 2017$1,105,000
+57.0%
28,400
-7.5%
0.01%
+42.9%
Q4 2016$704,000
+9.3%
30,700
+8.1%
0.01%0.0%
Q3 2016$644,000
-5.2%
28,4000.0%0.01%
-12.5%
Q2 2016$679,000
+27.9%
28,400
+8.0%
0.01%
+33.3%
Q1 2016$531,000
-61.5%
26,300
-1.5%
0.01%
-62.5%
Q4 2015$1,379,000
+23.5%
26,700
+1.9%
0.02%
+14.3%
Q3 2015$1,117,000
+3.4%
26,200
+10.5%
0.01%
+7.7%
Q2 2015$1,080,000
+24.9%
23,700
+3.9%
0.01%
+18.2%
Q1 2015$865,000
+18.8%
22,800
-10.6%
0.01%
+22.2%
Q4 2014$728,000
+19.0%
25,500
+5.4%
0.01%
+12.5%
Q3 2014$612,000
-11.2%
24,200
+2.5%
0.01%
-20.0%
Q2 2014$689,000
+12.8%
23,6000.0%0.01%0.0%
Q1 2014$611,00023,6000.01%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Grace Capital 270,832$6,467,0005.27%
Fernwood Investment Management, LLC 336,111$8,026,0003.84%
Tamarack Advisers, LP 595,000$14,268,0003.26%
First Light Asset Management, LLC 1,008,957$24,094,0003.08%
NEXPOINT ASSET MANAGEMENT, L.P. 1,540,679$36,791,0002.79%
CADIAN CAPITAL MANAGEMENT, LP 2,133,343$50,944,0002.25%
SECTORAL ASSET MANAGEMENT INC 606,189$14,476,0002.16%
Asymmetry Capital Management, L.P. 49,431$1,180,0002.12%
Parkman Healthcare Partners LLC 275,505$6,579,0001.90%
HARVEY CAPITAL MANAGEMENT INC 150,751$3,599,0001.60%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders